Your browser doesn't support javascript.
loading
Dual role of the peptide-loading complex as proofreader and limiter of MHC-I presentation.
Brunnberg, Jamina; Barends, Martina; Frühschulz, Stefan; Winter, Christian; Battin, Claire; de Wet, Ben; Cole, David K; Steinberger, Peter; Tampé, Robert.
  • Brunnberg J; Institute of Biochemistry, Biocenter, Goethe University Frankfurt, Frankfurt am Main 60438, Germany.
  • Barends M; Institute of Biochemistry, Biocenter, Goethe University Frankfurt, Frankfurt am Main 60438, Germany.
  • Frühschulz S; Institute of Biochemistry, Biocenter, Goethe University Frankfurt, Frankfurt am Main 60438, Germany.
  • Winter C; Institute of Biochemistry, Biocenter, Goethe University Frankfurt, Frankfurt am Main 60438, Germany.
  • Battin C; Institute of Immunology, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna 1090, Austria.
  • de Wet B; Immunocore Ltd., Abingdon OX14 4RY, United Kingdom.
  • Cole DK; Immunocore Ltd., Abingdon OX14 4RY, United Kingdom.
  • Steinberger P; Institute of Immunology, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna 1090, Austria.
  • Tampé R; Institute of Biochemistry, Biocenter, Goethe University Frankfurt, Frankfurt am Main 60438, Germany.
Proc Natl Acad Sci U S A ; 121(22): e2321600121, 2024 May 28.
Article en En | MEDLINE | ID: mdl-38771881
ABSTRACT
Antigen presentation via major histocompatibility complex class I (MHC-I) molecules is essential for surveillance by the adaptive immune system. Central to this process is the peptide-loading complex (PLC), which translocates peptides from the cytosol to the endoplasmic reticulum and catalyzes peptide loading and proofreading of peptide-MHC-I (pMHC-I) complexes. Despite its importance, the impact of individual PLC components on the presented pMHC-I complexes is still insufficiently understood. Here, we used stoichiometrically defined antibody-nanobody complexes and engineered soluble T cell receptors (sTCRs) to quantify different MHC-I allomorphs and defined pMHC-I complexes, respectively. Thereby, we uncovered distinct effects of individual PLC components on the pMHC-I surface pool. Knockouts of components of the PLC editing modules, namely tapasin, ERp57, or calreticulin, changed the MHC-I surface composition to a reduced proportion of HLA-A*0201 presentation compensated by a higher ratio of HLA-B*4001 molecules. Intriguingly, these knockouts not only increased the presentation of suboptimally loaded HLA-A*0201 complexes but also elevated the presentation of high-affinity peptides overexpressed in the cytosol. Our findings suggest that the components of the PLC editing module serve a dual role, acting not only as peptide proofreaders but also as limiters for abundant peptides. This dual function ensures the presentation of a broad spectrum of antigenic peptides.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Péptidos / Antígenos de Histocompatibilidad Clase I / Presentación de Antígeno Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Péptidos / Antígenos de Histocompatibilidad Clase I / Presentación de Antígeno Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article